New York State Common Retirement Fund Biotechnology

New York State Common Retirement Fund

$74.6 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ALEC Alector, Inc.	$154M	$19,000 0.0% of portfolio	10,310	Q3 2024 Reduced 60.05%
ELYM Eliem Therapeutics, Inc.	$109M	$19,000 0.0% of portfolio	10,500	Q3 2024 Reduced 21.05%
TCRX T Scan Therapeutics, Inc.	$42.2M	$19,000 0.0% of portfolio	6,169	Q3 2024 Reduced 69.3%
ADCT Adc Therapeutics Sa	$127M	$18,000 0.0% of portfolio	9,100	Q3 2024 Reduced 74.44%
APLT Applied Therapeutics Inc.	$25.5M	$18,000 0.0% of portfolio	21,200	Q3 2024 Reduced 45.5%
CDXC Chroma Dex Corp.	$370M	$18,000 0.0% of portfolio	3,400	Q3 2024 Reduced 91.01%
OVID Ovid Therapeutics Inc.	$43.7M	$18,000 0.0% of portfolio	18,986	Q2 2024 Added 1.67%
RAPT Rapt Therapeutics, Inc.	$37.1M	$18,000 0.0% of portfolio	11,549	Q2 2024 Reduced 0.02%
ABOS Acumen Pharmaceuticals, Inc.	$56.3M	$17,000 0.0% of portfolio	9,800	Q3 2024 Reduced 76.89%
MGNX Macrogenics Inc	$170M	$17,000 0.0% of portfolio	5,244	Q3 2024 Reduced 77.63%
NKTR Nektar Therapeutics	$174M	$17,000 0.0% of portfolio	18,800	Q3 2024 Reduced 78.59%
VERU Veru Inc.	$45.7M	$17,000 0.0% of portfolio	25,900	Q3 2024 Reduced 79.28%
CRDF Cardiff Oncology, Inc.	$206M	$16,000 0.0% of portfolio	3,600	Q3 2024 Reduced 91.63%
GALT Galectin Therapeutics Inc	$87.4M	$16,000 0.0% of portfolio	12,600	Q3 2024 Reduced 72.31%
KOD Kodiak Sciences Inc.	$232M	$16,000 0.0% of portfolio	1,631	Q2 2024 Added 2.51%
ATOS Atossa Therapeutics, Inc.	$101M	$15,000 0.0% of portfolio	15,800	Q3 2024 Reduced 82.0%
CADL Candel Therapeutics, Inc.	$336M	$15,000 0.0% of portfolio	1,700	Q3 2024 Reduced 90.0%
IPSC Century Therapeutics, Inc.	$43M	$14,000 0.0% of portfolio	13,743	Q1 2024 Reduced 0.21%
NAUT Nautilus Biotechnology, Inc.	$192M	$14,000 0.0% of portfolio	8,626	Q2 2024 Reduced 0.01%
DSGN Design Therapeutics, Inc.	$274M	$13,000 0.0% of portfolio	2,026	Q4 2023 Reduced 3.06%
AVTE Aerovate Therapeutics, Inc.	$57.9M	$11,000 0.0% of portfolio	4,294	Q2 2024 Reduced 0.42%
PBYI Puma Biotechnology, Inc.	$133M	$11,000 0.0% of portfolio	3,600	Q3 2024 Reduced 88.39%
TNYA Tenaya Therapeutics, Inc.	$45.9M	$10,000 0.0% of portfolio	7,039	Q2 2024 Added 0.49%
BDTX Black Diamond Therapeutics, Inc.	$78.5M	$9,000 0.0% of portfolio	4,400	Q3 2024 Reduced 79.34%
FHTX Foghorn Therapeutics Inc.	$218M	$9,000 0.0% of portfolio	1,871	Q2 2024 Reduced 22.75%
ATNM Actinium Pharmaceuticals, Inc.	$29.5M	$8,000 0.0% of portfolio	6,737	Q2 2024 Reduced 46.46%
HOWL Werewolf Therapeutics, Inc.	$40.8M	$8,000 0.0% of portfolio	5,100	Q3 2024 Reduced 87.22%
STTK Shattuck Labs, Inc.	$58.1M	$7,000 0.0% of portfolio	5,600	Q3 2024 Reduced 79.03%
EDIT Editas Medicine, Inc.	$132M	$6,000 0.0% of portfolio	4,394	Q3 2024 Reduced 84.74%
VRCA Verrica Pharmaceuticals Inc.	$327M	$6,000 0.0% of portfolio	9,076	Q2 2024 Reduced 7.09%
XBIT X Biotech Inc.	$91M	$6,000 0.0% of portfolio	1,600	Q3 2024 Reduced 92.63%
PRLD Prelude Therapeutics Inc	$31.6M	$5,000 0.0% of portfolio	3,622	Q3 2024 Reduced 81.06%
ELEV Elevation Oncology, Inc.	$14.2M	$3,000 0.0% of portfolio	5,200	Q3 2024 Reduced 86.97%
GBIO Generation Bio Co.	$36M	$3,000 0.0% of portfolio	2,682	Q2 2024 Added 0.86%
CABA Cabaletta Bio, Inc.	$59.8M	$2,000 0.0% of portfolio	990	Q3 2024 Reduced 98.8%
INMB Inmune Bio, Inc.	$154M	$2,000 0.0% of portfolio	500	Q3 2024 Reduced 95.69%
ADGI Adagio Therapeutics, Inc.	$505M	$2,000 0.0% of portfolio	4,000	Q3 2024 Reduced 95.2%
LCTX Lineage Cell Therapeutics, Inc.	$115M	$2,000 0.0% of portfolio	3,319	Q2 2024 Added 0.82%
OCGN Ocugen, Inc.	$147M	$2,000 0.0% of portfolio	2,600	Q3 2024 Reduced 97.49%
PYXS Pyxis Oncology, Inc.	$47M	$1,000 0.0% of portfolio	600	Q3 2024 Reduced 98.08%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.